Search Page

1

Cite

Share

Platelet hyperactivation and hyporesponsiveness at diagnosis in multiple myeloma persists during treatment initiation.

O'Sullivan LR, Meade-Murphy G, Gilligan OM, Mykytiv V, Cahill MR, Young PW. O'Sullivan LR, et al. Among authors: gilligan om. Thromb Res. 2021 Jul;203:186-189. doi: 10.1016/j.thromres.2021.05.004. Epub 2021 May 11. Thromb Res. 2021. PMID: 34033940 No abstract available.

Cite

Share

2

Cite

Share

Platelet hyperactivation in multiple myeloma is also evident in patients with premalignant monoclonal gammopathy of undetermined significance.

O'Sullivan LR, Meade-Murphy G, Gilligan OM, Mykytiv V, Young PW, Cahill MR. O'Sullivan LR, et al. Among authors: gilligan om. Br J Haematol. 2021 Jan;192(2):322-332. doi: 10.1111/bjh.16774. Epub 2020 Jun 1. Br J Haematol. 2021. PMID: 32478420

Cite

Share

3

Cite

Share

CALR mutation profile in Irish patients with myeloproliferative neoplasms.

Haslam K, Conneally E, Flynn CM, Cahill MR, Gilligan O, O'Shea D, Langabeer SE. Haslam K, et al. Among authors: gilligan o. Hematol Oncol Stem Cell Ther. 2016 Sep;9(3):112-5. doi: 10.1016/j.hemonc.2016.05.002. Epub 2016 Jun 23. Hematol Oncol Stem Cell Ther. 2016. PMID: 27352261 Free article.

Cite

Share

4

Cite

Share

Incidence of Contrast-Induced Nephropathy in Patients with Multiple Myeloma Undergoing Contrast-Enhanced Procedures.

Crowley MP, Prabhakaran VN, Gilligan OM. Crowley MP, et al. Among authors: gilligan om. Pathol Oncol Res. 2018 Oct;24(4):915-919. doi: 10.1007/s12253-017-0300-9. Epub 2017 Sep 13. Pathol Oncol Res. 2018. PMID: 28900871 Free article.

Cite

Share

5

Cite

Share

Gestation-specific D-dimer reference ranges: a cross-sectional study.

Murphy N, Broadhurst DI, Khashan AS, Gilligan O, Kenny LC, O'Donoghue K. Murphy N, et al. Among authors: gilligan o. BJOG. 2015 Feb;122(3):395-400. doi: 10.1111/1471-0528.12855. Epub 2014 May 15. BJOG. 2015. PMID: 24828148

Cite

Share

6

Cite

Share

Screening for CRLF2 overexpression in adult acute lymphoblastic leukemia.

Haslam K, Kelly J, Morris T, Connaghan G, Gilligan O, Browne P, Langabeer SE. Haslam K, et al. Among authors: gilligan o. Int J Lab Hematol. 2011 Dec;33(6):e17-9. doi: 10.1111/j.1751-553X.2011.01319.x. Epub 2011 Apr 4. Int J Lab Hematol. 2011. PMID: 21457190 No abstract available.

Cite

Share

7

Cite

Share

Perinatal determinants of D-dimer levels in a cross-sectional study of low risk pregnant women.

Murphy NM, Khashan AS, Broadhurst DI, Gilligan O, O'Donoghue K, Kenny LC. Murphy NM, et al. Among authors: gilligan o. Obstet Med. 2016 Jun;9(2):78-82. doi: 10.1177/1753495X15625547. Epub 2016 Feb 24. Obstet Med. 2016. PMID: 27512498 Free PMC article.

Cite

Share

8

Cite

Share

Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma.

Crowley MP, Quinn S, Coleman E, Eustace JA, Gilligan OM, O'Shea SI. Crowley MP, et al. Among authors: gilligan om. J Thromb Thrombolysis. 2015 Feb;39(2):245-9. doi: 10.1007/s11239-014-1140-z. J Thromb Thrombolysis. 2015. PMID: 25271000

Cite

Share

9

Cite

Share

Venous thromboembolism in patients with myeloma: incidence and risk factors in a "real-world" population.

Crowley MP, Eustace JA, O'Shea SI, Gilligan OM. Crowley MP, et al. Among authors: gilligan om. Clin Appl Thromb Hemost. 2014 Sep;20(6):600-6. doi: 10.1177/1076029614521280. Epub 2014 Jan 30. Clin Appl Thromb Hemost. 2014. PMID: 24486624 Free article. Clinical Trial.

Cite

Share

10

Cite

Share

Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma.

O'Gorman P, Laubach JP, O'Dwyer ME, Krawczyk J, Yee AJ, Gilligan O, Cahill MR, Rosenblatt J, Quinn J, Murphy PT, DiPietro H, Perera MR, Crotty GM, Cummings K, Hayden PJ, Browne P, Savell A, O'Leary HM, O'Keeffe D, Masone K, Hennessy BJ, Guerrero Garcia T, Scott K, Saeed K, Bianchi G, Dowling P, Tierney C, Richardson PG. O'Gorman P, et al. Among authors: gilligan o. Am J Hematol. 2022 May;97(5):562-573. doi: 10.1002/ajh.26491. Epub 2022 Feb 18. Am J Hematol. 2022. PMID: 35132679 Clinical Trial.

Cite

Share